Mercer Global Advisors’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-22,187
Closed -$1.68M 3708
2026
Q1
$1.68M Sell
22,187
-3,126
-12% -$235K ﹤0.01% 1277
2025
Q4
$1.89M Buy
25,313
+3,165
+14% +$231K ﹤0.01% 1134
2025
Q3
$1.49M Sell
22,148
-5,346
-19% -$355K ﹤0.01% 1163
2025
Q2
$1.79M Sell
27,494
-25,295
-48% -$1.52M ﹤0.01% 932
2025
Q1
$3.26M Sell
52,789
-8,607
-14% -$570K 0.01% 679
2024
Q4
$4.43M Sell
61,396
-11,012
-15% -$860K 0.01% 576
2024
Q3
$5.83M Buy
72,408
+188
+0.3% +$15K 0.01% 461
2024
Q2
$5.36M Buy
72,220
+17,130
+31% +$1.28M 0.01% 439
2024
Q1
$4.29M Sell
55,090
-50,517
-48% -$3.76M 0.01% 501
2023
Q4
$7.55M Buy
105,607
+5,921
+6% +$412K 0.02% 367
2023
Q3
$6.92M Sell
99,686
-2,947
-3% -$223K 0.03% 349
2023
Q2
$8.31M Sell
102,633
-316
-0.3% -$25.8K 0.03% 332
2023
Q1
$8.31M Buy
102,949
+2,706
+3% +$218K 0.04% 305
2022
Q4
$7.5M Buy
100,243
+11,583
+13% +$825K 0.04% 333
2022
Q3
$5.72M Buy
88,660
+354
+0.4% +$24.5K 0.03% 348
2022
Q2
$6.12M Buy
88,306
+10,538
+14% +$782K 0.04% 318
2022
Q1
$5.97M Buy
77,768
+8,600
+12% +$618K 0.04% 337
2021
Q4
$5.3M Buy
69,168
+1,849
+3% +$136K 0.03% 358
2021
Q3
$4.97M Buy
67,319
+12,099
+22% +$907K 0.03% 354
2021
Q2
$3.68M Buy
55,220
+9,244
+20% +$618K 0.03% 397
2021
Q1
$3.42M Buy
45,976
+19,914
+76% +$1.51M 0.03% 385
2020
Q4
$1.9M Buy
26,062
+14,377
+123% +$1.01M 0.02% 433
2020
Q3
$777K Sell
11,685
-253
-2% -$16K 0.01% 626
2020
Q2
$680K Sell
11,938
-946
-7% -$46.4K 0.01% 581
2020
Q1
$452K Buy
12,884
+4,682
+57% +$223K 0.01% 687
2019
Q4
$428K Sell
8,202
-1,521
-16% -$75.7K 0.01% 785
2019
Q3
$490K Sell
9,723
-982
-9% -$48.3K 0.01% 707
2019
Q2
$514K Sell
10,705
-423
-4% -$19.6K 0.01% 667
2019
Q1
$539K Buy
+11,128
New +$502K 0.02% 604

Other funds holding HOLX

Mercer Global Advisors's HOLX Position: Q2 2026 in Review

Mercer Global Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 22,187 shares — an estimated $1.68M sold.

Mercer Global Advisors first reported a position in HOLX in Q1 2019 and held it in 29 quarters. The position peaked at $8.31M in Q2 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Mercer Global Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Mercer Global Advisors sold 22,187 Hologic shares in Q2 2026, an estimated $1.68M.
  • Mercer Global Advisors first reported a position in Hologic in Q1 2019 and held it in 29 quarters.
  • Mercer Global Advisors's Hologic position peaked at $8.31M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.